业界动态国内医卫资讯
帕博利珠单抗联合立体定向体部放疗(SBRT)未能改善早期非小细胞肺癌(NSCLC)的无事件生存期(EFS)
Medscape News · 2026-11-14 01:00
摘要
一项基于有前景的2期试验信号而设计的联合治疗方案,在一项被提前终止的3期试验中遭遇了出乎意料的结果。Medscape Medical News
English
Pembrolizumab Fails to Improve EFS With SBRT in Early NSCLC
A combination built on a promising phase 2 signal met an unexpected fate in a phase 3 trial that was halted early. Medscape Medical News